CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual diseaseWenyi Lu, Mingfeng Zhao, Juanxia Meng et al.|Cancer Immunology Immunotherapy|2021Cited by 22
Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantationHairong Lyu, Mingfeng Zhao, Wenyi Lu et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 14
<p>Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation</p>Yili Jiang, Qi Deng, Qing Li et al.|OncoTargets and Therapy|2020Cited by 11
A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy PatientsWenyi Lu, Mingfeng Zhao, Xin Jin et al.|Cell Transplantation|2022Cited by 2
CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALLWenyi Lu, Mingfeng Zhao, Yunxiong Wei et al.|Blood|2020Cited by 0